Full text is available at the source.
AI-driven improvements to lab-evolved enzymes boost prime editing
Updated
Abstract
Essence
AI-guided redesign of prime editor reverse transcriptases improved stability, expression, and prime editing efficiency across ex vivo systems and in mice.
Evidence
Protein-engineering and preclinical genome-editing study redesigning reverse transcriptase domains with structure-informed AI, then testing edited constructs in human primary cells, multiple delivery modalities, and mice.
Caveat
This is platform and preclinical evidence, so stronger editing performance does not by itself establish therapeutic safety or effectiveness in humans.
Simplified